Host Julia Cartwright examines why Ozempic weight loss varies dramatically between individuals, exploring clinical trial data versus real-world outcomes. She breaks down key factors affecting results: diabetes status, biological sex, medication access, dosage consistency, and starting weight. Real studies show persistent medication access increases success threefold, while those with diabetes see lower percentage losses.
Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV
This content was created in partnership and with the help of Artificial Intelligence AI
続きを読む
一部表示